Boomerang
Early Stage
Digital health solution
Overview
Raised: $2,000
Total Commitments ($USD)
Platform
Title3Funds
Start Date
01/13/2023
Close Date
12/06/2023
Min. Goal
$10,000
Max. Goal
$5,000,000
Min. Investment
$250
Security Type
Equity - Common
Series
Pre-Seed
Funding Type
RegCF
Price Per Share
$1.00
Pre-Money Valuation
$10,000,000
Rolling Commitments ($USD)
Status
Active
Reporting Date
02/02/2023
Days Remaining
307
% of Min. Goal
20%
% of Max. Goal
0%
Likelihood of Max
Avg. Daily Raise
$100
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Location
Irvine, California
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B/B2C
Margin
Medium
Capital Intensity
Low
Boomerang, with a valuation of $10 million, is raising funds on Title3Funds. It is a digital health company focused on at-home diagnostic testing, customizable wellness plans, and strategic partnerships. The at-home test kits of Boomerang are convenient and accurate and span across tests, including diabetes, food sensitivity, food allergy, STDs, UTI, and COVID-19. Boomerang has a loyal customer base and expects to reach $25 million in revenue by 2023. Frank Gianotti founded Boomerang in October 2022. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5 million. The campaign proceeds will be used for marketing, equipment purchases, accounting fees, and general working capital.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$0 |
$0 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$0 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$0 |
$0 |
|
Short-Term Debt |
$0 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$0 |
Financials as of: 01/13/2023
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
